{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "GBp", "exchange": "LSE", "shortName": "ONDINE BIOMEDICAL INC. COM SHS ", "longName": "Ondine Biomedical Inc.", "messageBoardId": "finmb_4539236", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "fullExchangeName": "LSE", "financialCurrency": "CAD", "regularMarketOpen": 18.0, "averageDailyVolume3Month": 31824, "averageDailyVolume10Day": 24099, "fiftyTwoWeekLowChange": 3.0299997, "fiftyTwoWeekLowChangePercent": 0.20240478, "fiftyTwoWeekRange": "14.97 - 45.652", "fiftyTwoWeekHighChange": -27.652, "fiftyTwoWeekHighChangePercent": -0.6057128, "fiftyTwoWeekLow": 14.97, "fiftyTwoWeekHigh": 45.652, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.16, "sharesOutstanding": 194592992, "bookValue": 0.112, "fiftyDayAverage": 17.737, "fiftyDayAverageChange": 0.2630005, "fiftyDayAverageChangePercent": 0.014827789, "twoHundredDayAverage": 24.84745, "twoHundredDayAverageChange": -6.8474503, "twoHundredDayAverageChangePercent": -0.2755796, "marketCap": 35026740, "priceToBook": 160.71428, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": -2.7027028, "regularMarketPrice": 18.0, "marketState": "POSTPOST", "firstTradeDateMilliseconds": 1638777600000, "priceHint": 2, "regularMarketChange": -0.5, "regularMarketTime": 1683902050, "regularMarketDayHigh": 18.445, "regularMarketDayRange": "17.31 - 18.445", "regularMarketDayLow": 17.31, "regularMarketVolume": 37000, "regularMarketPreviousClose": 18.5, "bid": 17.0, "ask": 19.0, "symbol": "OBI.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1100 Melville Street", "address2": "Suite 888", "city": "Vancouver", "state": "BC", "zip": "V6E 4A6", "country": "Canada", "fax": "604 669 0533", "website": "https://www.ondinebio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; OND1002, a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and OND1003, a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Carolyn M. Cross C.F.A., CFA, M.B.A., MBA", "title": "Founder, CEO & Director", "fiscalYear": 2009, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nicolas G. Loebel Ph.D.", "title": "Pres, CTO & Director", "fiscalYear": 2009, "totalPay": {"raw": 152084, "fmt": "152.08k", "longFmt": "152,084"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Thomas  Dawson", "title": "Sr. VP of Corp. Devel.", "fiscalYear": 2009, "totalPay": {"raw": 132558, "fmt": "132.56k", "longFmt": "132,558"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Vipul  Shah", "title": "VP & CFO", "fiscalYear": 2006, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Angelika  Vance", "title": "VP of Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1262217600, "maxAge": 86400}}], "error": null}}